Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -15.61 | -1.43 | 2.67 | 0.61 |
| FCF Yield | 4.00% | 2.88% | 3.13% | 3.21% |
| EV / EBITDA | 11.44 | 12.16 | 13.91 | 18.51 |
| Quality | ||||
| ROIC | 6.59% | 7.26% | 8.66% | 8.71% |
| Gross Margin | 59.01% | 59.03% | 61.65% | 62.66% |
| Cash Conversion Ratio | 1.65 | 1.34 | 1.28 | 1.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.64% | 2.16% | 8.23% | 6.82% |
| Free Cash Flow Growth | 36.40% | -28.21% | -23.22% | 66.93% |
| Safety | ||||
| Net Debt / EBITDA | 1.36 | 1.39 | 1.43 | 1.57 |
| Interest Coverage | 12.48 | 13.27 | 21.94 | 14.49 |
| Efficiency | ||||
| Inventory Turnover | 1.93 | 1.85 | 1.84 | 1.88 |
| Cash Conversion Cycle | 195.92 | 190.81 | 197.83 | 186.13 |